Loniten (minoxidil) Drug Interactions
A total of 349 drugs are known to interact with Loniten (minoxidil).
- 4 major drug interactions
- 343 moderate drug interactions
- 2 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Loniten (minoxidil) and the medicines listed below.
- albuterol (Ventolin, Ventolin HFA, ProAir HFA, Proventil, Proventil HFA, ProAir RespiClick, AccuNeb, Respirol, Vospire ER, Volmax, ProAir Digihaler, Airet)
- allopurinol (Zyloprim, Aloprim, Lopurin)
- atenolol (Tenormin)
- Calci Mix (calcium carbonate)
- clonidine (Catapres, Kapvay, Clonidine ER, Catapres-TTS, Nexiclon XR, Duraclon, Jenloga)
- clopidogrel (Plavix)
- Coreg (carvedilol)
- finasteride (Proscar, Propecia)
- furosemide (Lasix, Diaqua-2, Lo-Aqua)
- hydralazine (Apresoline)
- Lasix (furosemide)
- levothyroxine (Synthroid, Levoxyl, Tirosint, Levothroid, Eltroxin, Euthyrox, Unithroid, Levothyrox, Eutroxsig, Levo-T, Oroxine, L Thyroxine Roche, Levotabs, Novothyrox, Tirosint-Sol, Levotec, Evotrox)
- metformin (Glucophage, Glumetza, Glucophage XR, Fortamet, Riomet)
- metoclopramide (Reglan, Maxolon, Metozolv ODT)
- Nephrocaps (multivitamin)
- Niferex (iron polysaccharide)
- Norvasc (amlodipine)
- perindopril (Aceon)
- spironolactone (Aldactone, CaroSpir)
- Tenormin (atenolol)
- Tums Ultra 1000 (calcium carbonate)
Loniten (minoxidil) disease interactions
There are 4 disease interactions with Loniten (minoxidil) which include:
- fluid retention/congestive heart failure
- ischemic heart disease
- pheochromocytoma
- renal failure/dialysis
More about Loniten (minoxidil)
- Loniten Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- En Español
- Drug class: vasodilators
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
